Arrowhead Pharmaceuticals Inc (ARWR)
Operating return on assets (Operating ROA)
| Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 98,346 | -601,080 | -205,002 | -178,507 | -149,036 |
| Total assets | US$ in thousands | 1,385,300 | 1,139,800 | 765,552 | 691,939 | 710,148 |
| Operating ROA | 7.10% | -52.74% | -26.78% | -25.80% | -20.99% |
September 30, 2025 calculation
Operating ROA = Operating income ÷ Total assets
= $98,346K ÷ $1,385,300K
= 7.10%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating ROA
Arrowhead Pharmaceuticals Inc
ARWR
7.10%
Biomarin Pharmaceutical Inc
BMRN
6.93%
Regeneron Pharmaceuticals Inc
REGN
10.57%